New York Life Investment Management’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.65M Sell
23,359
-3,221
-12% -$319K 0.02% 506
2026
Q1
$2.5M Buy
26,580
+3,128
+13% +$312K 0.02% 502
2025
Q4
$2.32M Buy
23,452
+1,018
+5% +$98.5K 0.02% 502
2025
Q3
$1.9M Sell
22,434
-266
-1% -$21K 0.02% 549
2025
Q2
$1.55M Buy
22,700
+346
+2% +$21.9K 0.01% 574
2025
Q1
$1.35M Buy
22,354
+84
+0.4% +$5.86K 0.01% 608
2024
Q4
$1.54M Sell
22,270
-2,584
-10% -$184K 0.02% 591
2024
Q3
$1.64M Sell
24,854
-4,073
-14% -$260K 0.02% 611
2024
Q2
$1.75M Buy
28,927
+293
+1% +$16.6K 0.02% 584
2024
Q1
$1.63M Sell
28,634
-972
-3% -$58.3K 0.02% 587
2023
Q4
$1.86M Sell
29,606
-1,371
-4% -$77.5K 0.02% 557
2023
Q3
$1.79M Sell
30,977
-272
-0.9% -$17.1K 0.02% 538
2023
Q2
$1.95M Buy
31,249
+571
+2% +$38.2K 0.02% 518
2023
Q1
$2.22M Buy
30,678
+311
+1% +$24.3K 0.02% 490
2022
Q4
$2.44M Sell
30,367
-371
-1% -$28.4K 0.03% 475
2022
Q3
$2.05M Sell
30,738
-553
-2% -$40.9K 0.02% 501
2022
Q2
$2.38M Buy
+31,291
New +$2.38M 0.03% 468

Other funds holding INCY

New York Life Investment Management's INCY Position: Q2 2026 in Review

New York Life Investment Management reduced its Incyte (INCY) stake by 12% in Q2 2026, selling an estimated $319K and leaving 23,359 shares worth $2.65M. The position accounts for 0.02% of the portfolio, ranked #506.

New York Life Investment Management first reported a position in INCY in Q2 2022 and has held it in 17 quarters since. 861 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • New York Life Investment Management held 23,359 shares of Incyte worth $2.65M as of Q2 2026.
  • New York Life Investment Management sold 3,221 Incyte shares in Q2 2026, an estimated $319K.
  • Incyte made up 0.02% of New York Life Investment Management's portfolio in Q2 2026, its #506 holding.
  • New York Life Investment Management first reported a position in Incyte in Q2 2022 and has held it in 17 quarters since.
  • 861 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.